9 April 2014 - Deborah Wilkes
Archived
Adcock Ingram has appointed Bidvest's Kevin Wakeford as chief executive officer following the resignation of Dr Jonathan Louw in the wake of the year-long battle for control of the South African pharmaceutical company.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.